ArticleMolecules (Basel, Switzerland)2026
Quantum Theoretical, Chemo-Computational, and Comparative Molecular Coupling Studies of Two Enantiomeric Naphthoquinones, Alkannin and Shikonin, and Their Corresponding Indole Derivatives.
Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
The use of computational tools has become widespread in drug discovery as an effective approach to guide the development of new therapeutic agents, including potential cancer drugs. In addition, plant-derived secondary metabolites have attracted considerable interest as a valuable source of bioactive compounds. Among these, alkannin and shikonin, two enantiomeric phyto naphthoquinones, have emerged as promising candidates for cancer therapy because of their anti-inflammatory properties and their ability to induce oxidative DNA damage in malignant cells. Related to the above commentaries, in the present study, the phyto naphthoquinones alkannin, shikonin, and their corresponding indole derivatives were evaluated employing density functional theory (DFT), followed by chemoinformatic analyses and molecular docking studies to evaluate, in silico, their potential activity against the cancer-related enzymes PARP-1, COX-2, and HDAC2, which are overexpressed in several types of cancer. The presence of the indole moiety in the phytomolecules increased their chemical reactivity, as exhibited by the calculated properties and the smaller LUMO-HOMO energy gap. In addition, the bioinformatic evaluation predicted that the target molecules may act as potential apoptosis agonists and antineoplastic agents. Finally, the performed molecular docking analysis suggested a stereoselective effect on the stability of ligand-protein binding complexes, particularly for alkannin, including relevant interactions with His201 and its indole derivative displaying interactions with His201, Tyr235, and Glu327 from the PARP-1 catalytic triad. Additionally, alkannin (-11.2 kcal/mol) and the corresponding indole derivative of shikonin (-10.14 kcal/mol) showed better interaction energies with COX-2 than naproxen (-8.75 kcal/mol). In the latter case, the inclusion of the indole moiety improved the binding affinity. In contrast, the affinity of the target compounds for HDAC2 decreased considerably with the indole derivatives in comparison with the reference compound BIZ.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.